Rick Winningham
Chief Executive Officer
Replay available
Theravance Biopharma, Inc. (TBPH) Q2 2025 Earnings Call
Theravance Biopharma, Inc. (NASDAQ: TBPH) Q2 2025 earnings conference call, held 2025-08-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Rhonda Farnham
Chief Business Officer
Anya Miller
Head of Development
Aziz Salah
Chief Financial Officer
Julian Harrison
Analyst, BTIG
Douglas So
Analyst, H.C. Wainwright
Deepen Jonna Chatterjee
Analyst, Jones
Ellen Horst
Analyst, TD Cowen
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Theravance Biopharma, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:04.380 Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the TheraVance 00:00:04.380 -- 00:00:08.840 BioPharma Second Quarter 2025 Conference Call. 00:00:08.840 -- 00:00:12.980 During the presentation, all participants will be in a listen-only mode. 00:00:12.980 -- 00:00:16.600 The question and answer session will follow the company's formal remarks. 00:00:16.600 -- 00:00:19.780 To ask a question, press star 1-1 on your telephone. 00:00:19.780 -- 00:00:24.860 If listening via webcast, please mute audio on your webcast device before asking 00:00:24.860 -- 00:00:30.040 a question over the phone. I will repeat these instructions after management completes 00:00:30.040 -- 00:00:33.880 their prepared remarks. Also, today's conference is being recorded. 00:00:33.880 -- 00:00:38.560 And now I would like to turn the call over to Rick Winningham, Chief Executive Officer. 00:00:38.560 -- 00:00:41.100 Please go ahead, sir. 00:00:41.660 -- 00:00:46.740 Good afternoon, and welcome to TheraVance BioPharma's Second Quarter 2025 00:00:46.740 -- 00:00:51.820 Earnings Results Conference Call. On slide 2, you'll find our 00:00:51.820 -- 00:00:56.600 forward-looking statements disclaimer, which covers certain risk factors which could 00:00:56.600 -- 00:01:01.760 cause actual results to differ materially from any such statements we might 00:01:01.760 -- 00:01:08.360 make in today's call, and which are described further in our filings with the SEC. 00:01:08.360 -- 00:01:13.860 Moving to slide 3, I'm joined today by Rhonda Farnham, Chief Business Officer, 00:01:13.860 -- 00:01:19.800 Anya Miller, Head of Development, and Aziz Salah, Chief Financial Officer. 00:01:19.860 -- 00:01:25.260 And turning to slide 4, we delivered an excellent quarte...